Prevalence of hepatitis B and hepatitis C virus in haemodialysis patients

Hepatitis B (HBV) and hepatitis C virus (HCV) infections continue to remain a significant global health challenge due its morbidity mortality profile. Almost 600,000 annual deaths are associated with the virus. Patients on haemodialysis at increased chance of acquiring infections. Infection among patients can lengthen hospital stay contribute further complications. infection is common patients. Cross-contamination through environmental surfaces, supplies, equipment, multiple-dose drug bottles, staff members modes causes transmission hepatis in facilities. The purpose this research review available information about prevalence Global for units reported studies ranged from 2.6% 22.9% 13.5% average while less than 10% some report ranging 2-20%. Literature has variable across different geographical regions. variation observed numerous risk factors contributing burden disease. Epidemiological data recent times lacking literature conduction population-based surveys be beneficial generalizing especially gulf countries where limited available.